The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells

Journal of Molecular and Cellular Cardiology

Volumn 81, Issue , 2015, Pages 62-70

  Bianchessi, Valentina ^a   Badi, Ileana ^a   Bertolotti, Matteo ^a   Nigro, Patrizia ^a   D'Alessandra, Yuri ^a   Capogrossi, Maurizio C ^b   Zanobini, Marco ^a   Pompilio, Giulio ^a   Raucci, Angela ^a   Lauri, Andrea ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Endothelial cells; LncRNA; MiRNA; Mitochondria; Senescence; Vascular aging

Indexed keywords

COMPLEMENTARY RNA; DOUBLE STRANDED RNA; HSA MIR 1973; HSA MIR 4485; LONG UNTRANSLATED RNA; MICRORNA; MITOCHONDRIAL RNA; PROTEIN ASNCMTRNA 2; PROTEIN P16; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HYDROGEN PEROXIDE; RNA; RNA, MITOCHONDRIAL;

ANIMAL TISSUE; AORTA; ARTICLE; CELL AGING; CELL CYCLE M PHASE; CONTROLLED STUDY; ENDOTHELIUM CELL; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; P16 GENE; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; AGING; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RADIATION RESPONSE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS;

AGING; ANIMALS; AORTA; BASE SEQUENCE; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MYOCYTES, SMOOTH MUSCLE; RNA; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 84939180087     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.01.012     Document Type: Article

References (66)

1. Erusalimsky J.D., Kurz D.J. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol 2005, 40:634-642. [S0531-5565(05)00086-0 [pii]]. 10.1016/j.exger.2005.04.010.
2. Fyhrquist F., Saijonmaa O., Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013, 10(5):274-283. [nrcardio.2013.30 [pii]]. 10.1038/nrcardio.2013.30.
3. Zaccagnini G., Gaetano C., Della Pietra L., Nanni S., Grasselli A., Mangoni A., et al. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem 2005, 280(15):14790-14798. [M414644200 [pii]]. 10.1074/jbc.M414644200.
4. AbuBakar S., Shu M.H., Johari J., Wong P.F. Senescence affects endothelial cells susceptibility to dengue virus infection. Int J Med Sci 2014, 11(6):538-544. [7896ijmsv11p0538 [pii]]. 10.7150/ijms.
5. Mao Z., Ke Z., Gorbunova V., Seluanov A. Replicatively senescent cells are arrested in G1 and G2 phases. Aging 2012, 4(6):431-435. 100467 [pii].
6. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev 2010, 24(22):2463-2479. [24/22/2463 [pii]]. 10.1101/gad.1971610.
7. Tertov V.V., Kaplun V.V., Mikhailova I.A., Suprun I.V., Orekhov A.N. The content of lipoperoxidation products in normal and atherosclerotic human aorta. Mol Cell Biochem 2001, 225:21-28. 1.
8. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
9. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8(9):729-740. [nrm2233 [pii]]. 10.1038/nrm2233.
10. Kotake Y., Cao R., Viatour P., Sage J., Zhang Y., Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007, 21(1):49-54. [21/1/49 [pii]]. 10.1101/gad.1499407.
11. Lauri A., Pompilio G., Capogrossi M.C. The mitochondrial genome in aging and senescence. Ageing Res Rev 2014, (18C):1-15. [S1568-1637(14)00066-X [pii]]. 10.1016/j.arr.2014.07.001.
12. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010, 12(4):503-535. 10.1089/ars.2009.2598.
13. Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 2007, 5(5):e110. [06-PLBI-RA-0089R5 [pii]]. 10.1371/journal.pbio.0050110.
14. Jazwinski S.M. The retrograde response: when mitochondrial quality control is not enough. Biochim Biophys Acta 2013, 1833(2):400-409. [S0167-4889(12)00050-X [pii]]. 10.1016/j.bbamcr.2012.02.010.
15. Santos J.H., Meyer J.N., Skorvaga M., Annab L.A., Van Houten B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 2004, 3(6):399-411. [ACE124 [pii]]. 10.1111/j.1474-9728.2004.00124.x.
16. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 2008, 121(Pt 7):1046-1053. [jcs.019372 [pii]]. 10.1242/jcs.019372.
17. Chen L.Y., Zhang Y., Zhang Q., Li H., Luo Z., Fang H., et al. Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control. Mol Cell 2011, 47(6):839-850. [S1097-2765(12)00593-X [pii]]. 10.1016/j.molcel.2012.07.002.
18. Martinez P., Thanasoula M., Carlos A.R., Gomez-Lopez G., Tejera A.M., Schoeftner S., et al. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 2010, 12(8):768-780. [ncb2081 [pii]]. 10.1038/ncb2081.
19. Kung J.T., Colognori D., Lee J.T. Long noncoding RNAs: past, present, and future. Genetics 2013, 193(3):651-669. [193/3/651 [pii]]. 10.1534/genetics.112.146704.
20. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012, 40(14):6391-6400. [gks296 [pii]]. 10.1093/nar/gks296.
21. Abdelmohsen K., Panda A., Kang M.J., Xu J., Selimyan R., Yoon J.H., et al. Senescence-associated lncRNAs: senescence-associated long noncoding RNAs. Aging Cell 2013, 12(5):890-900. 10.1111/acel.12115.
22. Gutschner T., Hammerle M., Diederichs S. MALAT1 - a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013, 91(7):791-801. 10.1007/s00109-013-1028-y.
23. Tripathi V., Shen Z., Chakraborty A., Giri S., Freier S.M., Wu X., et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013, 9(3):e1003368. [1003368PGENETICS-D-12-02155 [pii]]. 10.1371/journal.pgen.
24. Tsang W.P., Ng E.K., Ng S.S., Jin H., Yu J., Sung J.J., et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2009, 31(3):350-358. [bgp181 [pii]]. 10.1093/carcin/bgp181.
25. Zhang A., Zhou N., Huang J., Liu Q., Fukuda K., Ma D., et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 2013, 23(3):340-350. [cr2012164 [pii]]. 10.1038/cr.2012.164.
26. Burzio V.A., Villota C., Villegas J., Landerer E., Boccardo E., Villa L.L., et al. Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells. Proc Natl Acad Sci U S A 2009, 106(23):9430-9434. [0903086106 [pii]]. 10.1073/pnas.0903086106.
27. Mercer T.R., Neph S., Dinger M.E., Crawford J., Smith M.A., Shearwood A.M., et al. The human mitochondrial transcriptome. Cell 2011, 146(4):645-658. [S0092-8674(11), 00767-7 [pii]]. 10.1016/j. cell .2011.06.051.
28. Rackham O., Shearwood A.M., Mercer T.R., Davies S.M., Mattick J.S., Filipovska A. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA 2011, 17(12):2085-2093. [rna.029405.111 [pii]]. 10.1261/rna.029405.111.
29. Landerer E., Villegas J., Burzio V.A., Oliveira L., Villota C., Lopez C., et al. Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells. Cell Oncol (Dordr) 2011, 34(4):297-305. 10.1007/s13402-011-0018-8.
30. O'Callaghan N.J., Fenech M. A quantitative PCR method for measuring absolute telomere length. Biol Proced Online 2011, 13:3. 10.1186/1480-9222-13-3.
31. Martin-Ruiz C., Saretzki G., Petrie J., Ladhoff J., Jeyapalan J., Wei W., et al. Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span. J Biol Chem 2004, 279(17):17826-17833. [M311980200M311980200 [pii]]. 10.1074/jbc.
32. Yang W., Wu J.M., Bi A.D., Ou-Yang Y.C., Shen H.H., Chirn G.W., et al. Possible formation of mitochondrial-RNA containing chimeric or trimeric RNA implies a post-transcriptional and post-splicing mechanism for RNA fusion. PLoS One 2013, 8(10):e77016. [pone.0077016PONE-D-13-26567 [pii]]. 10.1371/journal.
33. Jima D.D., Zhang J., Jacobs C., Richards K.L., Dunphy C.H., Choi W.W., et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010, 116(23):e118-e127. [blood-2010-05-285403 [pii]]. 10.1182/blood-2010-05-285403.
34. Guerra-Assuncao J.A., Enright A.J. Large-scale analysis of microRNA evolution. BMC Genomics 2012, 13:218. [1471-2164-13-218 [pii]]. 10.1186/1471-2164-13-218.
35. Grillari J., Katinger H., Voglauer R. Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res 2007, 35(22):7566-7576. [gkm1065 [pii]]. 10.1093/nar/gkm1065.
36. Desjardins P., Frost E., Morais R. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol Cell Biol 1985, 5(5):1163-1169.
37. Matsui-Hirai H., Hayashi T., Yamamoto S., Ina K., Maeda M., Kotani H., et al. Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. J Pharmacol Exp Ther 2011, 337(3):591-599. [jpet.110.177584 [pii]]. 10.1124/jpet.110.177584.
38. Badi I., Burba I., Ruggeri C., Zeni F., Bertolotti M., Scopece A., et al. MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors. J Gerontol A Biol Sci Med Sci 2014, [glu180 [pii]]. 10.1093/gerona/glu180.
39. El Assar M., Angulo J., Vallejo S., Peiro C., Sanchez-Ferrer C.F., Rodriguez-Manas L. Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 2012, 3:132. 10.3389/fphys.2012.00132.
40. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., Bekaert S. Telomere length and cardiovascular aging: the means to the ends?. Ageing Res Rev 2011, 10(2):297-303. [S1568-1637(10)00110-8 [pii]]. 10.1016/j.arr.2010.11.001.
41. Ogami M., Ikura Y., Ohsawa M., Matsuo T., Kayo S., Yoshimi N., et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004, 24(3):546-550. [0000117200.46938.e701.ATV.0000117200.46938.e7 [pii]]. 10.1161/01.ATV.
42. Gorbunova V., Seluanov A., Pereira-Smith O.M. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem 2002, 277(41):38540-38549. [M202671200M202671200 [pii]]. 10.1074/jbc.
43. Chen Q.M., Prowse K.R., Tu V.C., Purdom S., Linskens M.H. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp Cell Res 2001, 265(2):294-303. [5182S0014-4827(01)95182-1 [pii]]. 10.1006/excr.2001.
44. Asano K., Nakamura M., Sato T., Tauchi H., Asano A. Age dependency of mitochondrial DNA decrease differs in different tissues of rat. J Biochem 1993, 114(3):303-306.
45. Miller F.J., Rosenfeldt F.L., Zhang C., Linnane A.W., Nagley P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res 2003, 31(11):e61.
46. Villota C., Campos A., Vidaurre S., Oliveira-Cruz L., Boccardo E., Burzio V.A., et al. Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes. J Biol Chem 2012, 287(25):21303-21315. [M111.326694 [pii]]. 10.1074/jbc.M111.326694.
47. Dong G., Broker T.R., Chow L.T. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 1994, 68(2):1115-1127.
48. Thierry F., Howley P.M. Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol 1991, 3(1):90-100.
49. Chellappan S., Kraus V.B., Kroger B., Munger K., Howley P.M., Phelps W.C., et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A 1992, 89(10):4549-4553.
50. Hyland P.L., McDade S.S., McCloskey R., Dickson G.J., Arthur K., McCance D.J., et al. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes. J Virol 2011, 85(21):10999-11006. [JVI.00160-11 [pii]]. 10.1128/JVI.00160-11.
51. Xue Y., Bellanger S., Zhang W., Lim D., Low J., Lunny D., et al. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res 2010, 70(13):5316-5325. [0008-5472.CAN-09-3789 [pii]]. 10.1158/0008-5472.CAN-09-3789.
52. Wiest T., Schwarz E., Enders C., Flechtenmacher C., Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002, 21(10):1510-1517. 10.1038/sj.onc.1205214.
53. Abdouh M., Chatoo W., El Hajjar J., David J., Ferreira J., Bernier G. Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons. PLoS One 2012, 7(2):e31870. [0031870PONE-D-11-12345 [pii]]. 10.1371/journal.pone.
54. Wang Y., Zang X., Chen P. High expression of p16INK4a and low expression of Bmi1 are associated with endothelial cellular senescence in the human cornea. Mol Vis 2012, 18:803-815.
55. Lai J., Lehman M.L., Dinger M.E., Hendy S.C., Mercer T.R., Seim I., et al. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells. RNA 2010, 16(6):1156-1166. [rna.2019810 [pii]]. 10.1261/rna.2019810.
56. Nikonov A., Molder T., Sikut R., Kiiver K., Mannik A., Toots U., et al. RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog 2013, 9(9):e1003610. 1003610PPATHOGENS-D-12-01792 [pii]. 10.1371/journal.ppat.
57. Maida Y., Yasukawa M., Furuuchi M., Lassmann T., Possemato R., Okamoto N., et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 2009, 461(7261):230-235. [nature08283 [pii]]. 10.1038/nature08283.
58. Sharma N.K., Reyes A., Green P., Caron M.J., Bonini M.G., Gordon D.M., et al. Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria. Nucleic Acids Res 2012, 40(2):712-725. [gkr758 [pii]]. 10.1093/nar/gkr758.
59. Vidaurre S., Fitzpatrick C., Burzio V.A., Briones M., Villota C., Villegas J., et al. Down-regulation of the antisense mitochondrial ncRNAs is a unique vulnerability of cancer cells and a potential target for cancer therapy. J Biol Chem 2014, [M114.558841 [pii]]. 10.1074/jbc.M114.558841.
60. Moreno-Moya J.M., Vilella F., Simon C. MicroRNA: key gene expression regulators. Fertil Steril 2014, 101(6):1516-1523. [S0015-0282(13)03205-6 [pii]]. 10.1016/j.fertnstert.2013.10.042.
61. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 2001, 36(8):1327-1347. [S0531-5565(01)00105-X [pii]].
62. Tsuchiya S., Fujiwara T., Sato F., Shimada Y., Tanaka E., Sakai Y., et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 2011, 286(1):420-428. [M110.170852 [pii]]. 10.1074/jbc.M110.170852.
63. Barral P.M., Rusch A., Turnell A.S., Gallimore P.H., Byrd P.J., Dobner T., et al. The interaction of the hnRNP family member E1B-AP5 with p53. FEBS Lett 2005, 579(13):2752-2758. [S0014-5793(05)00467-9 [pii]]. 10.1016/j.febslet.2005.03.095.
64. van der Watt P.J., Maske C.P., Hendricks D.T., Parker M.I., Denny L., Govender D., et al. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 2009, 124(8):1829-1840. 10.1002/ijc.24146.
65. Bandiera S., Ruberg S., Girard M., Cagnard N., Hanein S., Chretien D., et al. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 2011, 6(6):e20746. [0020746 PONE-D-10-05862 [pii]]. 10.1371/journal.pone.
66. Barrey E., Saint-Auret G., Bonnamy B., Damas D., Boyer O., Gidrol X. Pre-microRNA and mature microRNA in human mitochondria. PLoS One 2011, 6(5):e20220. [0020220 PONE-D-10-05717 [pii]]. 10.1371/journal.pone.